13-52029312-A-G

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_021645.6(UTP14C):ā€‹c.508A>Gā€‹(p.Ile170Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00596 in 1,614,194 control chromosomes in the GnomAD database, including 34 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.0041 ( 0 hom., cov: 32)
Exomes š‘“: 0.0062 ( 34 hom. )

Consequence

UTP14C
NM_021645.6 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: -0.171
Variant links:
Genes affected
UTP14C (HGNC:20321): (UTP14C small subunit processome component) Predicted to be involved in several processes, including meiotic cell cycle; rRNA processing; and spermatogenesis. Located in cytosol and nucleolus. [provided by Alliance of Genome Resources, Apr 2022]
ALG11 (HGNC:32456): (ALG11 alpha-1,2-mannosyltransferase) This gene encodes a GDP-Man:Man3GlcNAc2-PP-dolichol-alpha1,2-mannosyltransferase which is localized to the cytosolic side of the endoplasmic reticulum (ER) and catalyzes the transfer of the fourth and fifth mannose residue from GDP-mannose (GDP-Man) to Man3GlcNAc2-PP-dolichol and Man4GlcNAc2-PP-dolichol resulting in the production of Man5GlcNAc2-PP-dolichol. Mutations in this gene are associated with congenital disorder of glycosylation type Ip (CDGIP). This gene overlaps but is distinct from the UTP14, U3 small nucleolar ribonucleoprotein, homolog C (yeast) gene. A pseudogene of the GDP-Man:Man3GlcNAc2-PP-dolichol-alpha1,2-mannosyltransferase has been identified on chromosome 19. [provided by RefSeq, Aug 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007573843).
BP6
Variant 13-52029312-A-G is Benign according to our data. Variant chr13-52029312-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 235513.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=1}.
BS2
High Homozygotes in GnomAdExome4 at 34 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
UTP14CNM_021645.6 linkuse as main transcriptc.508A>G p.Ile170Val missense_variant 2/2 ENST00000521776.2 NP_067677.4 Q5TAP6A0A024RDV0
ALG11NM_001004127.3 linkuse as main transcriptc.*722A>G 3_prime_UTR_variant 4/4 ENST00000521508.2 NP_001004127.2 Q2TAA5
ALG11NR_036571.3 linkuse as main transcriptn.1059A>G non_coding_transcript_exon_variant 2/2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
UTP14CENST00000521776.2 linkuse as main transcriptc.508A>G p.Ile170Val missense_variant 2/21 NM_021645.6 ENSP00000428619.1 Q5TAP6
ALG11ENST00000521508.2 linkuse as main transcriptc.*722A>G 3_prime_UTR_variant 4/41 NM_001004127.3 ENSP00000430236.1 Q2TAA5

Frequencies

GnomAD3 genomes
AF:
0.00410
AC:
624
AN:
152184
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00142
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00248
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00745
Gnomad OTH
AF:
0.00623
GnomAD3 exomes
AF:
0.00354
AC:
891
AN:
251402
Hom.:
1
AF XY:
0.00380
AC XY:
516
AN XY:
135870
show subpopulations
Gnomad AFR exome
AF:
0.00129
Gnomad AMR exome
AF:
0.00281
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000555
Gnomad FIN exome
AF:
0.000647
Gnomad NFE exome
AF:
0.00626
Gnomad OTH exome
AF:
0.00489
GnomAD4 exome
AF:
0.00616
AC:
9000
AN:
1461892
Hom.:
34
Cov.:
106
AF XY:
0.00604
AC XY:
4392
AN XY:
727248
show subpopulations
Gnomad4 AFR exome
AF:
0.00125
Gnomad4 AMR exome
AF:
0.00295
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000556
Gnomad4 FIN exome
AF:
0.000861
Gnomad4 NFE exome
AF:
0.00751
Gnomad4 OTH exome
AF:
0.00626
GnomAD4 genome
AF:
0.00410
AC:
624
AN:
152302
Hom.:
0
Cov.:
32
AF XY:
0.00373
AC XY:
278
AN XY:
74472
show subpopulations
Gnomad4 AFR
AF:
0.00142
Gnomad4 AMR
AF:
0.00248
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000415
Gnomad4 FIN
AF:
0.000471
Gnomad4 NFE
AF:
0.00745
Gnomad4 OTH
AF:
0.00616
Alfa
AF:
0.00569
Hom.:
5
Bravo
AF:
0.00391
TwinsUK
AF:
0.00782
AC:
29
ALSPAC
AF:
0.00623
AC:
24
ESP6500AA
AF:
0.00227
AC:
10
ESP6500EA
AF:
0.00674
AC:
58
ExAC
AF:
0.00347
AC:
421
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00725
EpiControl
AF:
0.00593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenOct 01, 2024UTP14C: BP4, BS2 -
Likely benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsMay 09, 2016- -
ALG11-congenital disorder of glycosylation Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.69
CADD
Benign
7.9
DANN
Benign
0.94
DEOGEN2
Benign
0.0011
T
Eigen
Benign
-0.58
Eigen_PC
Benign
-0.62
FATHMM_MKL
Benign
0.061
N
LIST_S2
Benign
0.76
T
M_CAP
Benign
0.0023
T
MetaRNN
Benign
0.0076
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.8
L
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.17
N
REVEL
Benign
0.027
Sift
Benign
0.20
T
Sift4G
Benign
0.89
T
Polyphen
0.24
B
Vest4
0.042
MVP
0.23
MPC
0.099
ClinPred
0.0016
T
GERP RS
2.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.031
gMVP
0.071

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs73184339; hg19: chr13-52603448; COSMIC: COSV99074067; COSMIC: COSV99074067; API